WEED, Inc. (BUDZ) stock
Close on Oct 19, 2026Market cap $2.67MP/E –Yield –
WEED, Inc. reported revenue of $0 for the twelve months to Jun 30, 2026. At the latest close the market valued the company at $2.67M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $2.67M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $0
- Net income
- -$1.10M
- EPS, diluted
- -$0.01
- Book value per share
- -$0.01
- Diluted shares
- 148M
Trading
- Previous close
- $0.02
- Open
- $0.02
- Day's range
- $0.02 – $0.02
- Volume
- 133,274
- Average volume (20 days)
- 65,597
Market cap history
Month-end market cap since 2011, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | BUDZ | S&P 500 | Difference | BUDZ per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -34.3% | +0.6% | −34.9 pts | ||
| 3 months | -30.1% | +3.4% | −33.5 pts | ||
| Year to date | -58.4% | +13.3% | −71.7 pts | ||
| 1 year | -58.1% | +16.6% | −74.8 pts | ||
| 3 years | -80.0% | +86.4% | −166.4 pts | -41.5% | +23.1% |
| 5 years | -94.4% | +81.9% | −176.2 pts | -43.8% | +12.7% |
| 10 years | -97.9% | +318.9% | −416.7 pts | -32.0% | +15.4% |
Thirteen years at a glance
Fiscal years 2009 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases WEED filed with the SEC as exhibits to Form 8-K or 6-K
About WEED
Services-Commercial Physical & Biological Research
WEED, Inc. operates as a multi-national bio-pharmaceutical and real estate holding company focused on researching, developing, and applying cannabis-derived compounds for medical and industrial use. Through its operating subsidiaries, the company conducts cannabis genomic studies and breeding programs to classify the cannabis plant genus, preserve genetic cultivars, and develop validated strains aimed at treating human and animal ailments. It also holds a proprietary seedbank of cannabis and hemp genetics, maintains industrial hemp licenses for cultivation, nursery, and processing operations, and explores digital asset and technology integrations. Its primary targets and intended clientele include medical research centers, bio-pharmaceutical companies, healthcare professionals, and commercial medicinal markets.
Company profile, executives and historyWEED stock: common questions
What is WEED's stock price?
BUDZ closed at $0.02 on Oct 19, 2026, down 10.00% on the day.
What is WEED's market cap?
WEED was worth $2.67M at the close on Oct 19, 2026: the share price times the diluted shares outstanding.
What is BUDZ's P/E ratio?
WEED lost money over the twelve months to Jun 30, 2026 (diluted EPS -$0.01), so it has no meaningful P/E ratio.
How much revenue does WEED make?
WEED reported revenue of $0 for the twelve months to Jun 30, 2026.
Does WEED pay a dividend?
No. WEED has not paid a cash dividend over the last twelve months.
How has BUDZ stock performed over the past year?
Including dividends, BUDZ returned -58.1% over the past year, against +16.6% for the S&P 500.
Who are WEED's competitors?
Companies most similar to WEED by business, industry and size include CBIH, CRL, INCY, ABSI, MEDP.
See a number that looks wrong?